Will New Trial Solution Data Spark a Rally for this Dual-Listed Gen AI Clinical Trial Leader?
29 Fevereiro 2024 - 12:00PM
AllPennyStocks.com
Parkinson’s disease is a complex and debilitating disease with a
need for novel treatment options. This firm’s goal is to advance
its understanding of the biological markers and...
To read the full story on AllPennyStocks.com, click
here.
NetraMark (CSE:AIAI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
NetraMark (CSE:AIAI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024